FR2410675A1 - Procede de multiplication de virus - Google Patents

Procede de multiplication de virus

Info

Publication number
FR2410675A1
FR2410675A1 FR7833793A FR7833793A FR2410675A1 FR 2410675 A1 FR2410675 A1 FR 2410675A1 FR 7833793 A FR7833793 A FR 7833793A FR 7833793 A FR7833793 A FR 7833793A FR 2410675 A1 FR2410675 A1 FR 2410675A1
Authority
FR
France
Prior art keywords
rotavirus
virus
vaccine
antigen
multiplication process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7833793A
Other languages
English (en)
French (fr)
Other versions
FR2410675B1 (cg-RX-API-DMAC10.html
Inventor
June Dalziel Almeida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2410675A1 publication Critical patent/FR2410675A1/fr
Application granted granted Critical
Publication of FR2410675B1 publication Critical patent/FR2410675B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12361—Methods of inactivation or attenuation
    • C12N2720/12364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7833793A 1977-12-01 1978-11-30 Procede de multiplication de virus Granted FR2410675A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5009477 1977-12-01
GB5390677 1977-12-24

Publications (2)

Publication Number Publication Date
FR2410675A1 true FR2410675A1 (fr) 1979-06-29
FR2410675B1 FR2410675B1 (cg-RX-API-DMAC10.html) 1983-12-16

Family

ID=26266615

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7833793A Granted FR2410675A1 (fr) 1977-12-01 1978-11-30 Procede de multiplication de virus

Country Status (10)

Country Link
US (1) US4205131A (cg-RX-API-DMAC10.html)
JP (1) JPS5495789A (cg-RX-API-DMAC10.html)
CH (1) CH646194A5 (cg-RX-API-DMAC10.html)
DE (1) DE2851928A1 (cg-RX-API-DMAC10.html)
DK (1) DK152516C (cg-RX-API-DMAC10.html)
FI (1) FI63060C (cg-RX-API-DMAC10.html)
FR (1) FR2410675A1 (cg-RX-API-DMAC10.html)
GB (1) GB2009786B (cg-RX-API-DMAC10.html)
NL (1) NL191183C (cg-RX-API-DMAC10.html)
SE (1) SE445466B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US4624850A (en) * 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
EP0791055B1 (en) * 1994-11-10 2012-01-25 Baxter Healthcare S.A. Method for producing biologicals in protein-free culture
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6110724A (en) * 1996-10-18 2000-08-29 The Research Foundation For Microbial Diseases Of Osaka University Rotavirus antigen, vaccine and diagnostic agent for rotavirus infections, and a method for producing the antigen
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2801900B1 (fr) * 1999-12-03 2004-02-27 Pasteur Merieux Serums Vacc Methode de production de cellules animales adherentes
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
CA2640286C (en) * 2006-02-13 2018-01-02 Oncolytics Biotech Inc. Use of local immune suppression to enhance oncolytic viral therapy
CN101489587B (zh) * 2006-05-12 2015-05-27 伯哈拉特生物技术国际有限公司 一种可用作疫苗的组合物
CN117070475B (zh) * 2023-10-13 2023-12-29 金宇保灵生物药品有限公司 牛轮状病毒无血清悬浮培养方法及其产品和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366360A1 (fr) * 1976-09-30 1978-04-28 Wellcome Found Preparation virale utilisable comme reactif de diagnostic immunologique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366360A1 (fr) * 1976-09-30 1978-04-28 Wellcome Found Preparation virale utilisable comme reactif de diagnostic immunologique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CA1965 *
CA1975 *
EXBK/77 *
EXBK/78 *

Also Published As

Publication number Publication date
CH646194A5 (de) 1984-11-15
NL191183B (nl) 1994-10-03
FI783663A7 (fi) 1979-06-02
FI63060C (fi) 1983-04-11
FR2410675B1 (cg-RX-API-DMAC10.html) 1983-12-16
FI63060B (fi) 1982-12-31
DE2851928A1 (de) 1979-06-21
JPS5495789A (en) 1979-07-28
SE7812283L (sv) 1979-06-02
GB2009786A (en) 1979-06-20
DK152516C (da) 1988-08-01
NL7811763A (nl) 1979-06-06
NL191183C (nl) 1995-03-01
GB2009786B (en) 1982-08-11
DK152516B (da) 1988-03-07
US4205131A (en) 1980-05-27
JPS6150599B2 (cg-RX-API-DMAC10.html) 1986-11-05
SE445466B (sv) 1986-06-23
DK542878A (da) 1979-06-02
DE2851928C2 (cg-RX-API-DMAC10.html) 1987-06-04

Similar Documents

Publication Publication Date Title
FR2410675A1 (fr) Procede de multiplication de virus
Goulian et al. Enzymatic synthesis of DNA, XXIV. Synthesis of infectious phage phi-X174 DNA.
Hamlin Jr et al. Hydrogen-bonded dimers of adenine and uracil derivatives
Russell et al. Adenovirus antigens—a study of their properties and sequential development in infection
Gaida et al. Selective retention of viable cells in ultrasonic resonance field devices
CY1488A (en) Process for the production of human mono-clonal antibodies
AU2593192A (en) Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
ES8404186A1 (es) "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b".
PT73371B (en) A method for enhancing the yield of hepatitis a virus
Schmidt et al. Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers
Maxwell et al. Yeast uridine diphosphogalactose-4-epimerase, correlation between activity and fluorescence
Kalyanaraman et al. Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts
CN105588940A (zh) 一种检测塑化剂的时间分辨荧光免疫试剂盒的制备
JP3724821B2 (ja) Ａ型肝炎（ｈａｖ）の抗原およびワクチンの製造方法
Gordon Cancer procoagulant
GB1467503A (en) Process for the production of attenuated feline panleukopenia virus and vaccine
EP0317998B1 (en) Manufacturing method of optically-active 1,2-diols
Sinha et al. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
Schneider Properties of a serologically active substance from Leptospira icterohemorrhagiae (Wijnberg)
KR850006705A (ko) 항파상풍항체 생산 인체-인체 하이브리도마의 제조방법
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
JPS5675097A (en) Thermophilic aspartase and its preparation
Wiener et al. The chimpanzee VAB blood group system
Hiramoto et al. Immunohistochemical studies on the antigenic relationship of some muscle tumors to normal skeletal muscle cells
JPS6456620A (en) Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen

Legal Events

Date Code Title Description
TP Transmission of property